Taxing the Cyborg

Simple item page
dc.contributor.authorDavis, Tessa R.
dc.date.accessioned2023-01-18T19:13:12Z
dc.date.available2023-01-18T19:13:12Z
dc.date.issued2023-01-18
dc.description52 pagesen_US
dc.description.abstractThis Article considers how tax is poised to respond to CRISPR [Clustered Regularly Interspaced Short Palindromic Repeats] and similar emerging medical technologies with both therapeutic and so called enhancement applications. Doing so exposes gaps in current tax law as applied to the body and biotechnologies.en_US
dc.identifier.citation101 Or. L. Rev. 137en_US
dc.identifier.issn0196-2043
dc.identifier.urihttps://hdl.handle.net/1794/27924
dc.language.isoen_USen_US
dc.publisherUniversity of Oregon School of Lawen_US
dc.rightsAll Rights Reserved.en_US
dc.subjectTaxationen_US
dc.subjectBiotechnologyen_US
dc.subjectTax lawen_US
dc.titleTaxing the Cyborgen_US
dc.typeArticleen_US

Files

Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
4-Davis_OLR101-1.pdf
Size:
1019.5 KB
Format:
Adobe Portable Document Format
Description:
Download
License bundle
Now showing 1 - 1 of 1
Name:
license.txt
Size:
2.22 KB
Format:
Item-specific license agreed upon to submission
Description:
Download

Collections

Oregon Law Review : Vol.101, No.1 (2022)